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Background: Recently, we have highlighted the immunomodulatory activity of the standardized extracts of
Phyllanthus amarus and P. urinaria. The present study was carried out to correlate between the prevalent
constituents of the herbs and their inhibitory effects on phagocytic activity of human neutrophils.
Methods: The compounds, gallic acid, ellagic acid, corilagin, geraniin, phyllanthin and hypophyllanthin were
identified and quantitatively analyzed in the extracts of Phyllanthus amarus and P. urinaria obtained from Malaysia
and Indonesia by using a validated reversed phase high performance liquid chromatography (RP-HPLC) method.
The standardized extracts and the pure compounds were evaluated for their effects on chemotaxis, β2 integrin
(CD18) expression, phagocytosis and chemiluminescence of human phagocytes. Chemotactic activity was assessed
using the Boyden chamber technique, inhibition of CD18 expression and phagocytic ability were tested with the aid of
flow cytometry, while effect on the respiratory burst was investigated using a luminol-based chemiluminescence assay.
Results: All plant extracts strongly inhibited migration of the phagocytes with the Malaysian P. amarus depicting the
highest inhibitory activity. Amongst the compounds tested, geraniin demonstrated the strongest inhibitory activity on
chemotaxis of polymorphonuclear leukocytes (PMNs) and monocytes with IC50 values of 1.09 and 1.69 μM, respectively,
which were lower than that of ibuprofen. All plant extracts and pure compounds exhibited high inhibitory activity on
the oxidative burst of zymosan and PMA stimulated leukocytes. Geraniin and corilagin exhibited exceptionally strong
inhibition on the reactive oxygen species (ROS) activity with IC50 values lower than aspirin. The plant extracts exhibited
moderate inhibition of E. coli uptake by monocytes but weak effect on PMNs. Of all the compounds, phyllanthin at
50 μg/mL exhibited the highest engulfment inhibitory activity with percentage of phagocytizing cells of 14.2 and
27.1% for PMNs and monocytes, respectively. All plants and compounds tested possessed weak effect on CD18
expression on leukocytes except for hypophyllanthin and phyllanthin which exhibited significant inhibitory effect.
Conclusion: The strong inhibition of the extracts on the phagocytic activity of neutrophils was due to the presence of
their major constituents especially geraniin, corilagin, phyllanthin and hypophllanthin which were able to modulate the
innate response of phagocytes at different steps.
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Immune system is designed to protect the host by destroy-
ing and eliminating the invading pathogen. It requires the
timely interplay of a number of different types of cells
within a specific microenvironment to maintain the im-
mune homeostasis [1]. Human immune response is divided
into two main categories which include innate immunity,
initiated by phagocytosis of pathogens by phagocytic cells
and this orchestrates the adaptive immune system [2-4].
The two types of circulating phagocytes, neutrophils and
monocytes, are the main contributors to innate immune
system. In response to invasive bacterial infection, circu-
lating phagocytes perform a number of specific activities,
including migration of phagocyte cells to the site of infec-
tion, adherence to blood vessel walls, transmigration into
injured tissues, phagocytosis, degranulation, and reactive
oxygen species production [5]. Chemotaxis is referred to
the migration of phagocytes to the site of infection upon
the activation by either endogeneous chemoattractants
such as interleukin 8 (IL-8), leukotriene B4 (LTB4), platelet
activating factor (PAF) or exogeneous chemoattractants
such as formyl methionyl-leucyl-phenylalanine (fMLP)
derived from bacterial products [6-8].
Rapid regulation of adhesive interactions between phago-
cytes and vessel wall are essential in proper recruitment
of leukocytes and defensive against invasive pathogens.
Interactions between leukocytes and endothelial cells
are largely mediated by selectin family of receptors and
integrins. CD11/CD18 antigen complex have been re-
ported as an important group of adhesion molecule in-
volved in granulocyte interaction with other cells as well
as with antigens [9]. The interaction between phagocyte
and ligand at the site of infection leads to a sequential
event known as oxidative burst to kill the microbial in-
truders [10,11]. Oxidative burst involves the increased
oxygen consumption and generation of highly reactive
superoxide anion radical (O2
−) and hydroxyl radicals
(OH-) and hydrogen peroxides (H2O2). Despite its host
defense, exaggerated function of human phagocyte can
also be involved in cell and tissue damage associated
with severe inflammatory reactions and autoimmune
disorders [12]. Thus, modulation of phagocytic activity
through different pathways plays an essential role in
keeping them in a highly prepared state for any threat it
may encounter [13].
In this context, the utilization of medicinal plants and
their active components as immunomodulators to sub-
stitute conventional therapy has gained momentum in
recent years [14-18]. However, little is known about the
immunomodulatory activity of Malaysian medicinal
plants. The plants belonging to the genus Phyllanthus
(family: Euphorbiaceae) are widely distributed in tropical
and subtropical countries which have long been used in
folk medicine for the treatment of liver, asthma, kidneyand bladder problems and diabetes [19]. Besides, the
anti-viral properties of some Phyllanthus species, mainly
against hepatitis B have extended the medicinal proper-
ties of these plants in traditional medicine [20]. Amongst
all the species of Phyllanthus, P. amarus has gained a re-
markable interest in past few decades due to its variety
of organic compounds of medicinal importance includ-
ing flavonoids, ellagitannins, alkaloids, polyphenols, lig-
nans and triterpenes [21,22]. P. urinaria is yet another
species of Phyllanthus which has been reported to pos-
sess various biological activities including anti-tumor,
anti-angiogenic, anti-inflammation, anti-hypertensive,
anti-microbial and anti-viral activities [23-25]. The biosyn-
thesis of secondary metabolites of these plants has been
reported to vary among plants grown in different envir-
onmental factors [26,27]. Our previous studies on Phyl-
lanthus amarus and P. urinaria for their phagocytic
properties have revealed that the standardized methanol
extracts of these plants have the potential to exhibit
strong immunomodulatory effect on human neutrophils
[28]. In many previous studies, Phyllanthus species have
been reported for their wide spectrum of pharmaco-
logical activities [29,30]. However, investigations to cor-
relate the chemical constituents of the plants with their
biological and pharmacological effects were seldom re-
ported. The present study was carried out to investigate
the effects of the major components of the 80% ethanol
extracts of P. amarus and P. urinaria on phagocytic activ-
ity of human neutrophils in an effort to correlate the ef-
fectiveness of the plants with those of their components.
Methods
Chemicals and reagents
Serum opsonized zymosan A (Saccharomyces cerevisiae
suspensions and serum), lipopolysaccharide (LPS), Fluor-
escein isothiocyanate (FITC)-labelled opsonized Escheri-
chia coli, luminol (3-aminophthalhydrazide), phosphate
buffer saline tablet (PBS), Hanks Balance Salt Solutions
(HBSS), Ficoll, Hanks Balance Salt Solution (HBSS), N-
formyl-methionylleucyl-phenylalanine (fMLP), Tryphan
blue, MTT reagent, aspirin (purity 99%), ibuprofen (purity
99%), phorbol 12-myristate 13-acetate (PMA),and dimethyl-
sulfoxide (DMSO) were purchased from Sigma (St Louis,
MO, USA). Fetal calf serum was obtained from PAA La-
boratories (USA). CD18-FITC (anti-LFA-1β), isotype-
matched Immunoglobulin-FITC (IgG1-FITC) and FACS
lysing solution were obtained from Becton Dickinson,
USA. Chemiluminescence measurements were carried out
on a Luminoskan Ascent luminometer (Thermo Scientific,
UK). fMLP was stored as a stock solution of 10−8 M in
DMSO at −80°C and diluted in Hanks solution, prior to
assay. Phagocytic kit was purchased from Oregen Pharmagen,
USA. Haematoxylin and xylene for staining were obtained
from BDH, UK. A Boyden 48-well chamber with a 3 μm
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upper and lower compartments was purchased from
Neuro Probe (Cabin John, MD, USA). Phyllanthin and
hypophyllanthin (isolated based on method described in
previous study with purity >98%) [28]. Whereas gallic
acid, ellagic acid, corilagin and geraniin (purity >98%)
were purchased from ChromaDex (CA, USA). Methanol
HPLC grade, acetonitrile HPLC grade, and, trifluoroacetic
acid AR grade were obtained from E-Merck. Phagotest kit
was obtained from Glycotope Technology, Germany. The
flow cytometer BDFACS Canto II equipped with 488 nm
argon-ion laser was used. A CO2 incubator (Shell Lab,
USA), light microscope, and high-performance liquid
chromatograph (Waters 2998) (Leitz Watzler, Germany)
were also used in this assay.
Plant materials and preparation of extracts
The whole plants of Phyllanthus amarus and P. urinaria
were obtained from Marang, Kuala Terengganu, Malaysia
and Tanjung Anom, Northern Sumatra, Indonesia be-
tween February and June 2012. The plants were identified
by Dr Abdul Latif Mohamad of Faculty of Science and
Technology, Universiti Kebangsaan Malaysia (UKM), and
voucher specimens (P. amarus UKMB 30078 and P. uri-
naria UKMB 30077) were deposited at the Herbarium of
UKM, Bangi, Malaysia. No specific permissions were re-
quired for the collection of plant samples from Marang,
Kuala Terengganu, Malaysia and Tanjung Anom, Northern
Sumatra, Indonesia. The collection of plant samples did
not involve endangered or protected species and the study
was carried out at the Drug and Herbal Research Centre,
Faculty of Pharmacy, UKM. The aerial parts of P. amarus
and P. urinaria (100 g each) were ground and extracted
with 80% EtOH (3 × 3 L) at room temperature for 72 h
and filtered through Whatman No.1 filter paper ( Whatman,
England). The filtrate was collected and excess solvent
was evaporated under reduced pressure using rotary evap-
orator at 55°C to dryness to obtain dark yellowish green
ethanol extract of P. amarus (Malaysia, 10.8 g, 10.8%;
Indonesia, 10.1 g, 10.1%) and P.urinaria (Malaysia, 9.68 g,
9.7%; Indonesia, 7.48 g, 7.5%).
Quantitative determination of the major components of
plant extracts by HPLC
One hundred mg each of the 80% ethanol extracts of
Phyllanthus amarus and P. urinaria was dissolved into
10 mL of MeOH and 1 mg each of the reference standards
(gallic acid, ellagic acid, corilagin, geraniin, phyllanthin
and hypophyllanthin) in 1 mL of MeOH were ultra soni-
cated at ambient temperature for 10 min and filtered
through 0.45 μm Millipore Millex PTFE membrane
(Maidstone, Kent, UK). Phyllanthin and hypophyl-
lanthin (isolated based on method described in previous
study with purity >98%). Whereas gallic acid, ellagic acid,corilagin and geraniin (purity >98%) were purchased from
ChromaDex (CA, USA). The diluted solutions of the ex-
tracts and the reference standards were analyzed separ-
ately by HPLC using the following conditions: Column:
Reverse Phase, C-18 column (250 mm× 4.6 mm i.d., 5 μm,
Xbridge, Waters, Ireland), and detector: PDA (Waters
2998) of wavelength ranging from 205 to 270 nm. For the
analysis of the extracts and standard solutions of phenolic
compounds (gallic acid, ellagic acid, corilagin, geraniin)
gradient elution was used with acetonitrile 99.99% (solvent
A) and orthophosphoric acid 0.2% (solvent B) as mobile
phase at a flow rate of 0.6 mL/min with the following
procedure; 5-70% A (0 to 15 min), 70 to 95% A (15 to
30 min) and pump A had been hold at 95% for 20 min.
Corilagin was used as external standard for the identifi-
cation and quantification of the phenolic compounds.
Identification and quantification of the lignans (phyl-
lanthin and hypophyllanthin) were carried out based on
the chromatographic condition as described in our pre-
vious study [28]. The identification of each compound
was carried out by comparing the retention times and
UV-Vis spectra of the peaks with those obtained by the
injection of the standards. The calibration curves were
plotted with five concentrations each of the standard so-
lution of compounds versus the areas under the peaks.
The standard curves equations obtained from each
compounds were used to quantify the compounds in
the extracts.
Validation procedures for HPLC analysis
Validation of the HPLC method was carried out by de-
termination of linearity, precision, limits of quantifica-
tion (LOQ) and detection (LOD). LOD and LOQ were
calculated based on the standard deviation (σ) of the re-
sponses of the lowest concentration in calibration curve
of six runs (n =5) and the slope of the calibration curves
of external standards, respectively. Correlation coeffi-
cient (R2) was calculated from the calibration curves and
linearity was evaluated by linear calibration analysis.
Intra-assay and inter-assay validation were performed to
determine the precision of the method. Separately, one
concentration of extracts (10 mg/mL) and reference com-
pounds (1 mg/mL) were injected three times in one day
and on three different days. LOD and LOQ were calcu-
lated from the RSD and slope (S) of the calibration curves
using equations: LOD =3.3 × (RSD/S) and LOQ =10 ×
(RSD/S).
Isolation of human polymorphonuclear leukocytes and
monocytes
Ten mL of fresh venous blood was obtained in heparin-
containing tubes by aseptic vein puncture from healthy
human volunteers who fulfilled the following inclusion
criteria: non-smoker, fasted overnight and did not take
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aliquot into falcon tubes and equal amount of dextran
and PBS were added and the mixture was left for 45 min
at room temperature (26°C ±2) for sedimentation. The
PMN isolation was performed by using a modified
method of Oh et al. [31]. The supernatant was centri-
fuged by Ficoll-gradient separation and then washed
twice with cold distilled water for the lysis of red blood
cells. PMN cells sedimented at the bottom of the tubes.
Whereas the isolation of monocytes was performed by
using a modified method of Gmelig et al. [32]. Briefly,
10 mL of venous blood from healthy individual was di-
luted (1:1) with physiological saline before being applied
to the gradient. Diluted blood was then carefully layered
on lympho prep and centrifuged at 400 × g for 20 min.
After centrifugation the mononuclear cells formed a dis-
tinct band at the medium interface and was slowly re-
moved using pasteur pipette without removing the
upper layer. The fraction was diluted with PBS and cen-
trifuged at 250 × g for 10 min for the purification of
cells. These cells were then suspended in PBS and cell
suspension were counted using haemocytometer and
number of cells were adjusted to a final concentration of
1 × 106 cells/mL. The use of human blood was approved
by the Human Ethical Committee, Faculty of Medicine,
Universiti Kebangsaan Malaysia (approval number FF/
2012/Ibrahim/23-May/432-May 2012–August 2013).
Written informed consent was obtained from individ-
ual human volunteer participating in this study prior
to blood collection.Cell viability
Cytotoxicity of P. amarus and P. urinaria extracts and
standard compounds on monocytes was measured by
using MTT [33] while viability of PMNs was determined
by the standard trypan blue exclusion method [34]. For
the MTT assay, one hundred μL sample of five different
concentrations (6.25 - 100 μg/mL) of the samples were
filled into a 96 well round bottom microplate containing
100 μL cells suspension in RPMI 1640 10% FCS. The
plates were incubated for 24 h at 37°C and 5% CO2.
Twenty μl of MTT reagent (1 mg/mL) was added into
each well and incubated for 4 h at 37°C and 5% CO2.
The supernatant removed and the formazan produced
by cells in each well was dissolved in DMSO and the op-
tical densities (OD) were measured by ELISA readers at
570 nm [33]. The standard trypan blue exclusion assay
was carried out by incubating neutrophils (1 × 106/mL)
with 6.25 or 100 μg/mL of samples and 3.125 to
100 μg/mL of pure compounds in triplicate at 37°C for
2 h. Cell death was indicated by the blue dye uptake
and percentage viability was calculated from the total
cell counts [34].Chemiluminescence assay
Chemiluminescence assays were carried out as described
by Jantan et al. [34]. Briefly, 25 μL diluted whole blood
or 25 μL monocytes (adjusted to 1 × 106) or 25 μL PMN
(adjusted to 1 × 106) suspended in HBSS++were incu-
bated with 25 μL of sample with different concentrations
ranging from 6.25 to 100 μg/mL in 96 well flat bottom
microplate. Inducement of the cells was with 25 μL of
opsonized zymosan or PMA. This was followed by the
addition of 25 μL of luminol (1× 105 M) and the final
volume of each well was adjusted to 200 μL with HBSS++.
The microplate was then incubated at 37°C for 50 min in
the thermostatically controlled chamber of the lumin-
ometer. The control wells contained 0.6% DMSO, HBSS++,
luminol without sample and aspirin, a non-steroidal antiin-
flammatory drug (NSAID), was used as a standard drug.
The luminometer results were monitored as chemilumines-
cence RLU (reading per luminometer unit) with peak and
total integral values set with repeated scans at 30 s inter-
vals and 1 s points measuring time.
Chemotaxis assay
The assay was performed using a modified 48-well Boyden
chamber with formyl-methionylleucyl-phenylalanine (fMLP)
a bacterial peptide as a chemoattractant, as previously de-
scribed by Jantan et al. [34]. Aliquots of 25 μL of fMLP
(10 − 8 M) were added to the wells in lower chamber. Ser-
ial dilutions of 5 μL of each extract (6.25–100 μg/mL)
were added to the upper chamber containing 45 μL PMNs
(1 × 106 cells per mL) or 45 μL monocytes (1 × 106 cells
per mL) suspended in HBSS++. The final concentrations
of the samples in the mixture were adjusted to 10, 5, 2.5,
1.25, and 0.625 μg/mL. The control wells contained the
chemoattractant buffer HBSS++ and DMSO (1:1). The
cells were then incubated for one h at 37°C in a CO2 incu-
bator. Haematoxylin and xylene were used to fix and stain
migrated cells which had adhered to the distal part of the
filters. The cell migration distance was measured by using
a light microscope. Ibuprofen was used as a standard
drug.
Phagocytic assay
The assay was performed according to the protocol
given by the manufacturer (ORPEGEN Pharma). Briefly,
100 μL heparinized peripheral whole blood was incu-
bated with 20 μL pre-cooled FITC-labelled opsonized E.
coli and 20 μL of test samples (extracts: 6.25 and 100
μg/mL; pure compounds: 3.125 and 50 μg/mL) in a
closed shake water bath at 37°C for 10 min. Positive
control was without test sample under similar condition
while the negative control was without test sample and
remained on ice. At the end of the incubation time ice-
cold quenching solution was added to the mixture to
quench phagocytosis. Subsequently lysing solution was
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cytes. Cells were then washed twice and resuspended in
200 μL of DNA staining solution for cytometric discrimin-
ation of bacteria during leukocyte analysis. The phagocytic
ability of neutrophils and monocytes was determined by
flow cytometry using the blue-green excitation light
(488 nm argon-ion laser). Live populations were gated
by the software program in the scatter diagram (FCS
versus SSC). Phagocytic activity was determined as the
percentage of phagocytizing neutrophils and monocytes.
CD18 integrin expression of leukocytes
The CD18 integrin expression assay was performed using a
modified method of Mazzone et al. [35]. Peripheral blood
was obtained from heparinized venous blood of normal vol-
untary donors. Aliquots (100 μL) of whole blood were then
incubated in the presence or absence of samples with differ-
ent concentrations at 37°C for 30 min. Thereafter, cells
were stimulated with LPS (0.25 μg/mL) for 90 min at 37°C
in a CO2 incubator. Then, all the tubes were simultaneously
transferred into ice bath to stop the reaction. Subsequently
10 μL of CD18-FITC or Immunoglobulin G-FITC (negative
control) was added into the mixture. All the tubes were in-
cubated for 60 min on ice. FACS lysing solution was added
into each tube and incubated in dark for 20 min for the
lysis of red blood cells. The tubes were centrifuged at 250 g
for 5 min at 4°C and supernatant was removed from the
tubes and cells were washed with PBS (3×). 500 μl of PBS
was added into each tube and expression of adhesion mole-
cules was determined by flow cytometry and compared
with adhesion molecule expression of untreated cells. Neu-
trophils and monocytes were discriminated in terms of for-
ward and side scatter. Forward scatter is correlated to cell
size, whereas side scatter is related to cell granularity. The
specific mean fluorescence intensity for cells stained byFigure 1 Representative HPLC chromatograms of (a) P. amarus (Mal),
acid (1) at RT 8.172 min, geraniin (2) at RT 23.694 min,corilagin (3) at
wavelength of 270 nm. See Table 2 for legends.each antibody is reported as the ratio of the CD18 to that
of the negative control antibody. For each sample, 10,000
cells were analyzed.
Statistical analysis
All the data are presented as means ± standard error median
(SEM) from triplicate experiments and were analyzed using
statistical package for social sciences (SPSS) software version
20.0. The IC50 values were calculated using Graph PAD
Prism 6 Analysis software. Data were analyzed using a one-
way analysis of variance (ANOVA)for multiple comparisons.
P< 0.05 was considered to be statistically significant.
Results and discussion
Quantitative determination of the major components
of the 80% ethanol extracts of Phyllanthus amarus and
P. urinaria.
The chromatograms of the reversed-phase HPLC col-
umn of the 80% ethanol extracts of P. amarus and P.
urinaria showed four major peaks of gallic acid, gera-
niin, corilagin and ellargic acid, corresponding to reten-
tion times at 8.172, 23.694, 26.436 and 33.529 min,
respectively (Figure 1). The quantitative determination
of the lignans, phyllanthin and hypophyllanthin, their
precision, specificity, quantitation limit and detection
limit have been reported in our previous study [28]. The
identification of gallic acid (GA), ellagic acid (EA), cori-
lagin (Cor) and geraniin (Ger) was carried out by com-
paring with the retention times of standard solutions of
these compounds. The phenolic compounds identified
in the extracts were quantified by using corilagin as exter-
nal standard. The amounts of the major compounds are
shown in Table 1. The calibration curve plotted for stand-
ard solution of corilagin over the concentration range of
62.5–500 μg/mL showed a correlation coefficient (r2) of(b) P. urinaria (Mal) for identification and quantification of gallic
RT 26.436 min, ellagic acid (4) at RT 33.529 min at the
Table 1 Amount of major compounds found in Phyllanthus amarus and P.urinaria (μg/mL) obtained from HPLC
quantification analysis
Species Phyllanthin Hypophyllanthin Gallic acid Ellagic acid Corilagin Geraniin
PA (Mal) 103.50 114.00 163.30 601.29 313.41 170.49
PA (Ind) 79.10 121.85 142.92 219.06 413.42 234.52
PU (Mal) 16.80 19.50 103.48 231.34 159.37 173.17
PU (Ind) 1.9 3.91 93.05 346.12 379.23 199.50
PA: Phyllanthus amarus, PU: Phyllanthus urinaria, Mal: Malaysia, Ind: Indonesia.
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by results of relative standard deviation (RSD %) of mean
area under peak 1.81% and mean of retention time values
0.93% for interday assay, whereas the % RSD values for
intra-assay precision of peak area and retention time were
3.68 and 1.09%. Limit of detection (LOD) and limit of
quantification (LOQ) of corilagin were found to be 1.86
and 5.65 ng/mL, respectively.
Quantitative determination of the major compounds by
HPLC indicated that P. amarus from Malaysia contained
the highest amounts of phyllanthin (103.5 μg/mL), gallic
acid (163.3 μg/mL) and ellagic acid (601.29 μg/mL), while
P. amarus from Indonesia contained the highest amount
of hypophyllantin (121.85 μg/mL). Corilagin (379.23 μg/mL)
was found in highest concentration in the extract of P. uri-
naria from Indonesia. The variations in the amounts of
the major compounds in the plants of similar species col-
lected from different geographical locations were partly
due to the different environmental factors related to alti-
tude and genetic adaptation of the populations growing at
different altitudes to specific environment [26].Figure 2 Percentage inhibition (%) of Phyllanthus sp. and their major
SEM (n =3). Significance of differences with respective control: *P< 0.05. SeChemotaxis assay
The cell viability test was carried out using trypan blue
and MTT assays for PMNs and monocytes, respectively,
to evaluate the cytotoxicity of extracts of Phyllanthus
amarus and P. urinaria as well as the standard com-
pounds. The extracts and the standard compounds at
concentrations ranging from 6.25 to 100 μg/mL showed
more than 95% of cell viability except for phyllanthin
and hypophyllanthin which possessed cell viability >95%
at concentrations ranging from 0.3125 to 5 μg/mL. The
results indicate that leucocytes were viable in the reac-
tion mixtures in the presence of the extracts and the
compounds which were non toxic and could poten-
tially modulate the cellular immune response. The in-
hibitory activities of the extracts and standard
compounds at the serial dilutions of 10 to 0.625 μg/
mL, on the migration of PMNs towards the chemo-
attractant (fMLP), were determined and their percent-
age inhibitions (%) were shown in Figure 2.
Chemoattractant buffer (DMSO and HBSS, 1:1 ratio)
was used as a control and ibuprofen was used as acompounds on PMN and monocytes chemotaxis. Data are mean ±
e Table 2 for legends.
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P. amarus and P. urinaria from both Malaysia and
Indonesia on human phagocytes in response to N-
formylmethionyl-leucylphenylalanine (fMLP) was sup-
pressed in a concentration-dependent manner. Amongst
the extracts, P. amarus from Malaysia depicted the most
potent inhibitory activity on PMNs and monocytes migra-
tions with IC50 values of 1.22 and 1.44 μg/mL, respectively
(Table 2). Amongst the major compounds identified in P.
amarus and P. urinaria, geraniin, corilagin and ellagic
acid demonstrated lower IC50 values than that of ibu-
profen, with geraniin being the strongest inhibitor with
IC50 values of 1.09 and 1.69 μM against PMNs and
monocytes, respectively. Ibuprofen was used in previ-
ous study as a positive control and it was found to be
the most effective NSAIDS in blocking the migration
of PMNs [36]. There was an inversed correlation be-
tween the amount of phenolic compounds and the
chemotactic activity of fMLP stimulated phagocytic
cells. This is in congruity with previous studies which
indicated that the presence of galloyl moeties in pheno-
lics contribute to the inhibition of migration of fMLP
stimulated migration of phagocytes by potent inhibition of
activity of enzyme elastase [37,38].Table 2 IC50 values (μg/mL) of ROS inhibitory and chemotaxis
major compounds on phagocytes (mean ± SEM, n =3)
Sample Chemotaxis
fMLP Zymosan
PMNs MNCs Whole Blood PMNs
PA (Mal) 1.22 ± 0.10 1.44 ± 0.80 0.95 ± 0.24 0.58 ± 1.8
PA (Ind) 1.84 ± 0.01 2.35 ± 0.23 8.14 ± 1.71 0.12 ± 0.0
PU (Mal) 1.46 ± 0.10 2.84 ± 0.30 1.52 ± 0.53 1.00 ± 1.2
PU (Ind) 2.21 ± 0.90 2.92 ± 0.14 9.74 ± 1.09 1.64 ± 0.5
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GA: Gallic acid, EA: Ellagic acid, Ger: Geraniin, Cor: Corilagin, Phyll: Phyllanthin, Hypo
Mal: Malaysia, Ind: Indonesia.
IC50 values in μM are in parentheses.Phagocytic assay
The ability of PMNs and monocytes to phagocytize op-
sonized E. coli was evaluated by phagotest kit and ana-
lyzed by flow cytometry. The E coli was opsonized with
immunoglobulin and complement of pooled sera. The
phagocytic activity was calculated based on the percent-
age of E. coli ingestion by phagocytes. The complement
opsonized microbes were recognized by complement
surface receptors on leukocytes. The Fab portion of the
antibody binds to the antigen, whereas the constant part
of the antibody (Fc) binds to an Fc receptor on the
phagocyte, facilitating phagocytosis [39]. The extracts of
Phyllanthus amarus and P. urinaria at 100 and 6.25 μg/
mL exhibited moderate inhibition of E. coli uptake by
monocytes but weak effect on neutrophils, as shown in
Figure 3 and Table 3. At 100 μg/mL, all plant extracts
showed moderate engulfment inhibitory activity with
percentage of phagocytizing cells ranging from 53.70 to
66.68% for monocytes. The engulfment inhibitory activ-
ity at normal condition at 37°C was used as a positive
control and normal condition at 0°C as negative control
(Table 3). Except for phyllanthin and hypophyllanthin,
all pure compounds did not show significant activity
on the bacterial engulfment by human leukocytes.activities of Phyllanthus amarus and P. urinaria and their
Chemiluminescence
PMA
MNCs Whole Blood PMNs MNCs
0 0.10 ± 0.17 1.24 ± 0.98 0.42 ± 0.75 0.56 ± 0.30
5 2.19 ± 2.55 6.02 ± 1.33 1.34 ± 0.59 1.27 ± 0.80
1 1.23 ± 0.88 1.98 ± 1.09 0.45 ± 0.23 0.26 ± 0.12
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0.75 ± 0.12



















































phyll: Hypophyllanthin, PA: Phyllanthus amarus, PU: Phyllanthus urinaria,
Figure 3 Representation of E. coli engulfment by (a) Neutrophils and (b) Monocytes treated with plant extracts and their major
compounds at 100 μg/mL except phyllanthin and hypophyllanthin at 50 μg/mL. (A) negative control, (B) positive control, (C) P. amarus
(Mal), (D) P. amarus (Ind), (E) P. urinaria (Mal), (F) P. urinaria (Ind), (G) Gallic acid, (H) Ellagic acid, (I) Geraniin, (J) Corilagin, (K) Phyllanthin,
(L) Hypophyllanthin.
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ment inhibitory activity with percentage of phagocytiz-
ing cells of 14.2 and 27.1% for PMNs and monocytes,
respectively. Phyllanthin might be the major contributor
of phagocytic activity of the plant extracts. The results
suggest that the moderate inhibitory of intake comple-
ment and opsonized E. coli of the compounds might be
due to the inhibition of the complement surface recep-
tors on leukocytes.
Inhibition of CD18 expression assay
The effects of the P. amarus and P. urinaria extracts on
β2 integrins (CD18) expression on PMNs and mono-
cytes are shown in Table 4. The inhibition of CD18 ex-
pression by plant extracts and compounds was testedwith the aid of flow cytometry. Except foe phyllanthin
and hypophyllanthin, the plant extracts and pure com-
pounds possessed weak inhibition of CD18 expression
on human leukocytes. Phyllanthin and hypohyllanthin
depicted significant inhibition at 50 μg/mL with percent-
age of CD18 expression of 67.17% and 61.56% for PMNs
and monocytes, respectively. The expression of CD18-
containing integrins is essential for the normal function-
ing of neutrophil in vivo. It plays an important role of
cytotoxic killing by T cells. On the other hand, the binding
of human leukocyte integrins (CD11a/CD18, CD11b/
CD18 and CD11c/CD18) to lipopolysaccharide (LPS), a
bacterial endotoxin, triggers deleterious systemic inflam-
matory responses when released into blood circulation,
causing organ damage [40,41]. The suppression of LPS
Table 3 Percentage of phagocytic activity (%) of neutrophils and monocytes at various concentrations of Phyllanthus
amarus and P. urinaria extracts and their major compounds (mean ± SEM, n =3)
Sample (μg/mL) Neutrophils Monocytes
100 50 6.25 3.125 100 50 6.25 3.125
PA (Mal) 75.60 ± 1.82 88.20 ± 1.17 53.70 ± 0.15 65.68 ± 0.15
PA (Ind) 81.65 ± 2.21 89.29 ± 2.67 66.68 ± 3.16 74.60 ± 2.76
PU (Mal) 78.13 ± 2.07 89.60 ± 0.98 59.08 ± 1.66 68.80 ± 1.66
PU (Ind) 73.30 ± 3.32 79.40 ± 1.07 61.86 ± 2.81 72.22 ± 3.02
GA 88.60 ± 1.52 95.90 ± 1.97 76.50 ± 2.18 77.80 ± 1.71
EA 85.20 ± 1.19 88.18 ± 2.13 75.50 ± 1.97 67.10 ± 2.31
Ger 76.00 ± 3.05 80.80 ± 1.06 76.08 ± 3.16 84.90 ± 0.91
Cor 85.50 ± 2.82 86.10 ± 0.32 80.70 ± 1.51 85.38 ± 1.04
Phyll 14.20 ± 1.08 34.91 ± 0.09 27.10 ± 0.55 52.10 ± 0.68
Hypophyll 49.11 ± 1.04 80.50 ± 0.87 64.6 ± 0.51 67.0 ± 1.07
Positive control 91.60 ± 1.15 84.6 ± 4.84
See Table 2 for legends.
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of inflammatory processes by inhibiting the expression of
these integrins.
Chemiluminescence assay
Preliminary screening of the plant extracts on whole blood
showed that P. amarus and P. urinaria from Malaysia
exhibited high inhibitory activity for luminol-enhanced
chemiluminescence with IC50 values of 0.95 and
1.52 μg/mL, respectively, for zymosan induced and 1.24
and 1.98 μg/mL, respectively, for PMA induced (Table 2
and Figure 4). The Malaysian Phyllanthus samples were
also more potent than the Indonesian samples against
PMNs and monocytes. The extracts of P. amarus possessed
higher inhibitory activity compared to P. urinaria. ThisTable 4 Percentage of CD18 expression (%) on neutrophils an
extracts and their major compounds
Sample (μg/mL) Neutrophils
100 50 6.25 3.
PA (Mal) 79.62 ± 1.82 87.10 ± 1.23
PA (Ind) 81.65 ± 2.21 89.29 ± 2.67
PU (Mal) 82.90 ± 1.08 90.62 ± 1.80
PU (Ind) 87.15 ± 3.39 93.20 ± 3.39
GA 81.33 ± 1.80 88.77 ± 2.41
EA 86.14 ± 2.01 90.18 ± 1.07
Ger 89.40 ± 1.21 93.10 ± 1.23
Cor 92.10 ± 1.02 95.80 ± 0.98
Phyll 67.17 ± 1.34 79.20
Hypophyll 74.70 ± 0.09 80.90
Positive control 93.93 ± 0.54
See Table 2 for legends.
(Mean ± SEM, n =3).might be associated with the presence of high amount of
bioactive phenolic compounds in P. amarus compared to
P. urinaria. Geraniin and corilagin exhibited IC50 values of
0.36 and 0.58 μM, respectively, in zymosan stimulated
whole blood, and 0.21 and 0.35 μM, respectively, in
PMA stimulated whole blood. Their IC50 values were
lower than those of aspirin, indicating that they were
more potent than the positive control. Aspirin was used
as the positive control based on a previous report that
the drug inhibited luminol-enhanced chemiluminescence
of human leukocytes [42].
The extracts of Phyllanthus species and their major
components were further investigated for their effects
on the oxidative burst of PMA or zymosan stimulated
PMNs and monocytes. The plant extracts from bothd monocytes at various concentrations of Phyllanthus
Monocytes
125 100 50 6.25 3.125
70.79 ± 2.13 85.68 ± 1.10
62.39 ± 1.87 89.29 ± 1.51
76.20 ± 1.54 88.98 ± 2.76
85.18 ± 0.51 85.41 ± 1.69
68.60 ± 1.20 76.50 ± 2.18
62.20 ± 0.57 77.10 ± 1.99
82.90 ± 1.71 88.40 ± 1.75
79.51 ± 1.10 85.38 ± 1.32
± 2.92 61.56 ± 0.98 72.21 ± 1.26
± 1.65 74.42 ± 0.77 75.15 ± 1.48
84.79 ± 0.55
Figure 4 Percentage inhibition (%) of ROS inhibitory activity of Phyllanthus sp. and their major compounds on PMA stimulated whole
blood (a), PMNs (b) and MNCs (c) assayed by luminol amplified chemiluminescence. Data are mean ± SEM (n =3). Significance of
differences with respective control: *P< 0.05. See Table 2 for legends.
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inhibition of ROS production from zymosan and PMA
stimulated leukocytes. Geraniin and corilagin exhibited
exceptionally strong inhibition on ROS activity against
PMNs and monocytes. The IC50 values of geraniin and
corilagin were 0.18 and 0.56 μM, respectively, for zymo-
san induced and 0.13 and 0.24 μM, respectively for PMA
induced PMNs. Their IC50 values were similarly much
lower than those of aspirin against monocytes, indicating
that they were more potent than the positive control.
Figure 4 shows the percentage inhibition of oxidative
burst of the Phyllanthus species and the pure compounds
on PMA induced leukocytes, depicting a dose-dependent
relationship.
It is increasingly proposed that ROS plays a key role in
structural alteration of DNA, dysregulation of cytoplasmic
and nuclear signal transduction and effect the activity ofthe proteins and genes that respond to stress and which
act to regulate the genes that are related to cell prolifer-
ation, differentiation and apoptosis pathways. ROS is
produced by phagocytes in response to a variety of
stimulators for bacterial killing and amplification of in-
flammatory response. The NADPH oxidase complex
plays essential role in ROS production. The activation
of NADPH oxidase is induced by receptor ligation and
engulfment of microbial pathogens, chemical or various
stimuli, such as PMA, fMLP, or zymosan. In this study
ROS generation was assessed upon stimuli with PMA
which crosses the cellular membrane and binds to pro-
tein kinase C independent of cell receptor interaction
and serum opsonized zymosan which stimulates neu-
trophils via their surface complement receptor (CR3)
[43]. The present study indicates that similar inhibitory
activity of ROS generation was noticed in phagocytes
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that P. amarus and P. urinaria have the capacity to inhibit
ROS production through two different pathways.
Besides the defensive roles of phagocytes against infec-
tious microbes, the phagocyte-microbe interactions be-
tween excessively or inappropriately deployed can damage
host tissues and contribute to the pathogeny of various
immune and nonimmune chronic inflammatory diseases.
Therefore, the strong inhibition of the major compounds
of P. amarus and P. urinaria on phagocytic activity of hu-
man phagocytes indicates that the extracts and their major
constituents have the potential to be developed into
agents for the treatment of a variety of disorders in-
cluding inflammation.
Conclusions
The HPLC analysis methods proposed in this study enable
identification and quantification of all major compounds
found in the 80% ethanol extracts of P. amarus and P.
urinaria. The HPLC quantification analysis indicated
the presence of high amount of phenolic compounds in
the plant extracts obtained from both Malaysia and
Indonesia. The in vitro studies revealed that, the plant
extracts, especially Malaysian P. amarus exhibited po-
tent inhibitory activity of ROS generation and chemo-
tactic activity of phagocytes stimulated by different
stimuli. The results suggest that the immune regulatory
action of the plant extracts act through various path-
ways. The phenolic compounds, geraniin, corilagin and
ellagic acid demonstrated strong inhibition against
the leukocytes. Geraniin and corilagin also exhibited
exceptionally strong inhibition on ROS activity against
PMNs for zymosan induced PMA induced leukocytes.
In contrast, the phenolic compounds did not show sig-
nificant effect on phagocytic activity and β2 integrins
expression of phagocytes. The inhibitory activity pos-
sessed by plant extracts at these steps could be due the
contribution of phyllanthin and hypophyllanthin which
exhibited potent inhibitory action on both phagocytic
and CD18 expression of phagocytes. Thus, the in vitro
study suggest that the presence of high levels of the
major compounds of P.amarus and P.urinaria re-
ported in this study could be the major contributors to
the strong immunomodulatory effect of the plant.
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